S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
New CBOE “special perk” helps traders target income every weekend (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
New CBOE “special perk” helps traders target income every weekend (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
New CBOE “special perk” helps traders target income every weekend (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
New CBOE “special perk” helps traders target income every weekend (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way

Sintx Technologies (SINT) Stock Price, News & Analysis

$0.42
+0.03 (+7.63%)
(As of 12/8/2023 ET)
Compare
Today's Range
$0.38
$0.43
50-Day Range
$0.35
$0.82
52-Week Range
$0.34
$15.10
Volume
179,001 shs
Average Volume
268,385 shs
Market Capitalization
$1.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00

Sintx Technologies MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
5,100.9% Upside
$22.00 Price Target
Short Interest
Bearish
13.14% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.59 out of 5 stars


SINT stock logo

About Sintx Technologies Stock (NASDAQ:SINT)

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

SINT Stock Price History

SINT Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Ascendiant Remains a Buy on Sintx Technologies (SINT)
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Maxim Group Keeps Their Buy Rating on Sintx Technologies (SINT)
SINT - Sintx Technologies, Inc.
Maxim Group Sticks to Its Buy Rating for Sintx Technologies (SINT)
Sintx Technologies (SINT) Gets a Buy from Ascendiant
SiNtx Technologies Down 44% on Equity Offer Pricing
SINT.OQ - | Stock Price & Latest News | Reuters
See More Headlines
Receive SINT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sintx Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/14/2023
Today
12/10/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/13/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SINT
Fax
N/A
Employees
41
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$22.00
High Stock Price Target
$22.00
Low Stock Price Target
$22.00
Potential Upside/Downside
+5,100.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-12,040,000.00
Net Margins
-397.27%
Pretax Margin
-397.27%

Debt

Sales & Book Value

Annual Sales
$1.56 million
Book Value
$10.52 per share

Miscellaneous

Free Float
4,217,000
Market Cap
$1.80 million
Optionable
Not Optionable
Beta
1.65
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Dr. B. Sonny Bal J.D. (Age 61)
    M.B.A., M.D., Ph.D., Chairman, President & CEO
    Comp: $441.96k
  • Mr. David Francis O'Brien (Age 58)
    Executive VP & COO
    Comp: $332.05k
  • Mr. Michael Marcroft
    Vice President of Sales & Marketing
  • Ms. Gina Moss
    Director of Operations














SINT Stock Analysis - Frequently Asked Questions

Should I buy or sell Sintx Technologies stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sintx Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SINT shares.
View SINT analyst ratings
or view top-rated stocks.

What is Sintx Technologies' stock price target for 2024?

1 brokerages have issued 1-year price objectives for Sintx Technologies' shares. Their SINT share price targets range from $22.00 to $22.00. On average, they expect the company's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 5,100.9% from the stock's current price.
View analysts price targets for SINT
or view top-rated stocks among Wall Street analysts.

How have SINT shares performed in 2023?

Sintx Technologies' stock was trading at $9.68 on January 1st, 2023. Since then, SINT stock has decreased by 95.6% and is now trading at $0.4230.
View the best growth stocks for 2023 here
.

Are investors shorting Sintx Technologies?

Sintx Technologies saw a increase in short interest in November. As of November 15th, there was short interest totaling 536,300 shares, an increase of 740.6% from the October 31st total of 63,800 shares. Based on an average daily volume of 135,800 shares, the short-interest ratio is presently 3.9 days. Currently, 13.1% of the company's stock are sold short.
View Sintx Technologies' Short Interest
.

When is Sintx Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024.
View our SINT earnings forecast
.

How were Sintx Technologies' earnings last quarter?

Sintx Technologies, Inc. (NASDAQ:SINT) posted its earnings results on Tuesday, November, 14th. The company reported ($0.81) earnings per share (EPS) for the quarter. The business had revenue of $0.68 million for the quarter. Sintx Technologies had a negative trailing twelve-month return on equity of 85.77% and a negative net margin of 397.27%.

When did Sintx Technologies' stock split?

Sintx Technologies shares reverse split on Monday, December 19th 2022. The 1-100 reverse split was announced on Monday, December 19th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What other stocks do shareholders of Sintx Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sintx Technologies investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Heat Biologics (HTBX), T2 Biosystems (TTOO), AIM ImmunoTech (AIM), Aytu BioPharma (AYTU), Blink Charging (BLNK), Bionano Genomics (BNGO) and Nuwellis (CHFS).

How do I buy shares of Sintx Technologies?

Shares of SINT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:SINT) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -